Skip to content

Multimode functional magnetic resonance imaging may predict antiepileptic drugs response on epileptic patients

Multimode functional magnetic resonance imaging could predict response of newly diagnosed epileptic patients to antiepileptic drugs

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR-OCC-14004161
Enrollment
Unknown
Registered
2014-01-13
Start date
2010-05-01
Completion date
Unknown
Last updated
2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Epilepsy

Interventions

Newly diagnosed epileptic patients:AEDs
Control:None
DR epileptic patients:AEDs
WH epileptic patients:AEDs

Sponsors

The First Affiliated Hospital of Chongqing Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
12 Years to 64 Years

Inclusion criteria

Inclusion criteria: The common inclusion criteria were: (1) patients with a definite diagnose of epilepsy with partial secondary generalized seizures. The types of epilepsy and the seizure types were defined according to the International League Against Epilepsy (ILAE) [34, (1989) Proposal for revised classification of epilepsies and epileptic syndromes. Commission on Classification and Terminology of the International League Against Epilepsy. Epilepsia 30: 389-399.]; (2) patients willing to participate in this study. The idiosyncratic inclusion for newly diagnosed epileptic patients were (1) patients who never received AEDs; (2) the time from patients suffered from first seizure attack to they came to us was less than 3 months. The idiosyncratic inclusion for DR epileptic patients was patients with frequently seizure onsets (more than four seizures per month) and refractory to maximal doses of four AEDs, including Valproate, Carbamazepine, Topiramate, Lamotrigine or Levetiracetam. The idiosyncratic inclusion criteria for WH patients: (1) patients without seizure onsets for contiguous 5 years at least; (2) no epileptic wave had been found from the last Holter monitoring electroencephalogram scans before we prepared to stop medicine.

Exclusion criteria

Exclusion criteria: The exclusion criteria were: (1) patients with focal abnormality in the structure MRI; (2) patients with progressive central neurological diseases or tumor; (3) patients with only acute symptomatic or non-epileptic seizures; (4) patients with a history of psychiatry or mood problems; (5) patients with neurological deficiencies, such as hearing or visual loss; (6) patients suffering from intolerable adverse events during follow up; (7) patients who lost to follow up; (8) patients fearing confined spaces; (9) patients with a head motion larger than 2.5mm translation or 2.5 degree rotation when scanning.

Design outcomes

Primary

MeasureTime frame
fALFF;FA;

Countries

China

Contacts

Public ContactWang Xuefeng

The First Affiliated Hospital of Chongqing Medical University

xfyp@163.com+86 023-89012878

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026